Stay updated on Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.

Latest updates to the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe 403 Forbidden view was replaced by the ClinicalTrials.gov page shell, with navigation and footer visible and the revision updated to v3.7.2. Study details are not displayed.SummaryDifference0.6%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden message, replacing the previous study record view and blocking access to the study details and documents.SummaryDifference18%

- Check57 days agoChange DetectedThe study page's revision tag was updated to v3.6.6, indicating a small administrative update to the record. This change does not alter study details or participant information.SummaryDifference0.0%

- Check78 days agoChange DetectedThe site’s revision label now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a software update was applied to the page.SummaryDifference0.0%

Stay in the know with updates to Exenatide in Adolescent Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exenatide in Adolescent Type 2 Diabetes Clinical Trial page.